Back to search

Article

PSMB5-centered immunotherapy resistance signature predicts prognosis and drives CD8+ T cell exclusion in lung adenocarcinoma

2026-08-18

Abstract excerpt

<h4>Background</h4> Immune checkpoint inhibitors (ICIs) achieve limited response rates in lung adenocarcinoma (LUAD), and the mechanisms underlying immunotherapy resistance remain poorly understood. Robust predictive biomarkers are urgently needed. <h4>Methods</h4> We integrated single-cell transcriptomic data, multi-cohort bulk RNA-seq datasets, and spatial transcriptomics to systematically identify an immunoth...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b40ceeea-57cc-5f88-8c10-83178b7c2e9d
DOI
10.64898/2026.08.16.26360303
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PSMB5-centered immunotherapy resistance signature predicts prognosis and drives CD8+ T cell exclusion in lung adenocarcinomaDOI 10.64898/2026.08.16.26360303
Select a neighboring publication to make it the new centre.